Hanspeter Gerber
Company: Codeable Therapeutics
Job title: Chief Scientific Officer & Co-Founder
Seminars:
Selecting Optimal Linker-Payload Technology to Complement Your Target 9:30 am
Choosing the optimal linker-payload technology in liquid tumors Delving into linker-payload selection in solid tumors Marrying ideal linker-payload and antibody to best complement your target and expand therapeutic windowsRead more
day: Conference Day Two